TUSTIN,
Calif., Nov. 1, 2024 /PRNewswire/ -- Pangea
Laboratory has partnered with Unilabs, a leading European provider
of clinical laboratory testing and diagnostic imaging services, to
bring the Bladder CARE™ Assay to Switzerland. Under this agreement, the Bladder
CARE™ Assay will be covered by insurance, enhancing access for
patients. This strategic collaboration aims to streamline cancer
diagnostics in Switzerland, with
plans for a broader rollout of Bladder CARE™ across Europe. The partnership underscores Pangea
Laboratory's commitment to making innovative diagnostic solutions
widely accessible globally.
Awarded Breakthrough Device Designation by the FDA, the Bladder
CARE™ Assay analyzes DNA methylation biomarkers to detect bladder
cancer and upper tract urothelial carcinoma (UTUC) from urine
samples, which can be conveniently collected at home. With
sensitivity, specificity, and NPV exceeding 93% for both
conditions, along with quantitative results, the Bladder CARE™
Assay stands out from other commercially available tests.
"Through this strategic partnership with Pangea Laboratory,
Unilabs reinforces its commitment to driving innovation in
diagnostics, bringing Bladder CARE™ to Switzerland as a next-generation solution that
empowers early detection and advances patient care," said
Patrick Bornand, Head of Pathology,
Genetics & Oncology at Unilabs Switzerland.
"Pangea Laboratory is committed to delivering non-invasive
healthcare solutions that reduce patient burden while delivering
highly accurate results. We are happy that the Unilabs team shares
our vision, and the belief that Bladder CARE™ sets a new standard
in the diagnosis of bladder cancer and UTUC," said Dr. Yap
Ching Chew, COO of Pangea
Laboratory.
About Pangea Laboratory
Founded in 2014, Pangea Laboratory is a Clinical Laboratory
Improvement Amendments (CLIA) certified, and College of American
Pathologists (CAP) accredited diagnostics company dedicated to
simplifying diagnosis for critical health conditions. For more
information, visit https://pangealab.com/bladdercare/.
About Unilabs
Unilabs is a leading European provider
of clinical laboratory testing and medical diagnostic imaging
services, with over 109 laboratories and 44 imaging units across 12
countries. Headquartered in Geneva, Unilabs performs over 106 million
diagnostic tests and 1 million radiology exams annually, serving
healthcare providers, governments, pharmaceutical companies, and
the public. Unilabs focuses on swift, accurate diagnosis and aims
to lead the shift from treatment to prediction and prevention,
driven by advancements in molecular and genetic testing. For more
information, visit www.unilabs.com.
Contacts:
Pangea Laboratory
Abigail
Kang, Marketing Manager
akang@pangealab.com
Unilabs Switzerland
Inês Camilo, Marketing
Specialist
ines.camilo@unilabs.com
Logo -
https://mma.prnewswire.com/media/1781233/Pangea_Logo_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/pangea-laboratory-partners-with-unilabs-to-introduce-bladder-care-assay-in-switzerland-advancing-non-invasive-cancer-diagnostics-across-europe-302293546.html